Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.5 GBX | 0.00% | -1.35% | -12.05% |
Mar. 04 | Beximco names Iqbal Ahmed as managing director | AN |
Jan. 30 | Beximco Pharmaceuticals to strengthen portfolio as interim profit up | AN |
Business Summary
Number of employees: 5,700
Sales per Business
BDT in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Formulations and Active Pharmaceutical Ingredients
100.0
%
| 34,669 | 100.0 % | 39,267 | 100.0 % | +13.26% |
Sales per region
BDT in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bangladesh
100.0
%
| 34,669 | 100.0 % | 39,267 | 100.0 % | +13.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | 05-02-28 | |
Director/Board Member | - | - | |
Mehboobul Haque
PRN | Corporate Officer/Principal | - | - |
Human Resources Officer | - | - | |
Shawkat Haider
PRN | Corporate Officer/Principal | - | - |
Roksana Hassan
AUD | Comptroller/Controller/Auditor | - | - |
Shamim Momtaz
PRN | Corporate Officer/Principal | - | 06-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Director/Board Member | - | 90-12-31 | |
Director/Board Member | - | 92-12-31 | |
Director/Board Member | - | - | |
Director/Board Member | - | 20-07-29 | |
Director/Board Member | 64 | 20-11-29 | |
Reem Shamsuddoha
BRD | Director/Board Member | 36 | 20-11-29 |
Director/Board Member | 64 | 21-01-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 446,112,089 | 342,099,318 ( 76.68 %) | 0 | 76.68 % |
Company contact information
Beximco Pharmaceuticals Ltd.
19 Dhanmondi R/A Road No. 7
1205, Dhaka
+880 2 5861 1001
http://www.beximcopharma.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BXPHARMA Stock
- BXP Stock
- Company Beximco Pharmaceuticals Limited